The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
And …… you spoke too soon.
That slow bleed out has continued.
Despite the decent news at Mbe.
Aim is fickle and it is very much month to month however there is Plenty to look forward to in Q3 and 4.
The only thing that potentially looms is funding… for Bibemi and the company itself. If the Canadian bank pull through for the CLP that that drilling is locked in.
I can’t see why oriole dips so much when it goes through a quiet news period. Am I missing something?
Morning mate, for sure I think that this will have its day and that’s why I have been quiet.
I used to use this as a platform to vent my frustrations and ultimately new the BoD were listening.
Recently I’ve been quietly confident in oriole so longer feel the need to come on here. Just sit and wait.
While I want it to be sooner rather than later I also understand that anything major is likely to occur around the time the Mbe assays will be released.
I’ve been relatively quiet here recently.
I used to think it was lack of news flow that put us in the doldrums but it can only be the market.
I thought last weeks RNS was rather significant and yet we saw a rise of 5% followed by a few red days.
What more does it take….?
The BoD have taken salary sacrifices to prolong the shoe string budget and they make every penny count. Maybe that is part of the problem?
Whilst the Canadian bank are helping to fund the CLP, a potential JV partner at bibemi **?
We still need money to keep the lights on.
The ‘imminent’ elephant oil IPO has taken a year and counting. The EIA in Turkey worth multi millions to oriole is also taking its time.
All the while oriole continue to deliver excellent results. Just wondering what else the market wants.
As a comparison , Rockfire , a genuinely rubbish company which moves from old license to old license, puts a few new drill holes in and digs up some old assays to rework has been steadily rising of the last few months to 0.32 and a mcap of £6m
This baffles me!!! That company is a full on turd and yet it somehow climbs past oriole who genuinely has huge positives.
Some things I won’t understand and the market is one of them. Makes zero sense
Absolutely awesome RNS. Great video by Claire as well explaining the results and intersections.
Early stage work and hugely encouraging results. Sit tight and wait for the assays. Drilling in Q3/4
Mbe could be a monster!!!
0.1836 +
They are all buys. Just check get a quote on your trading platform and it gives you a price to buy and to sell.
To sell £4K it will quote you around 0.1770
The trade tracker is wrong, if you want to double check just use your trading platform.
Hunniford -
He said “he wouldn’t put a specific number on it but He mentioned the £10m which the Canadian bank put on the CLP (10% of the CLP is £1m)
Seneca being worth the current mcap alone + more
Bibemi being worth the current mcap and more.
As well as other legacy assets
That means there is a huge disconnect between the real value of oriole and what the market values them at.
Always the story but I agree.